Coronavirus Update: Trump Spreads Confusion On Drug Treatments, Biogen Fires China Flight Employee
Executive Summary
Daily round-up of the latest coronavirus news: Trump's chloroquine mix-up, imported cases rise in China, Biogen sacks employee over China travel, Vir's Scango talks about its COVID-19 efforts, Roche's Actemra study plus COVID-19 pipeline infographic.
You may also be interested in...
Strong Q1 For Chugai But Virus Uncertainties Loom
Chugai says coronavirus business impact has been minor so far but cautions this could change after a strong first quarter.
Mid-Sized Pharmas Mostly Seeing Valuations Rise During Pandemic
Six of seven mid-sized companies enjoyed valuation increases over the first quarter, with four firms up by 7.5% or more. Some are benefiting from direct involvement in addressing the COVID-19 pandemic.
Tech Transfer Roundup: Coronavirus Research Collaborations Respond To Pandemic
Recent collaborations involving Ridgeback, Themis, Junshi, Moleculin, Can-Fite, Pluristem and Beroni highlight the intense increase in research in how to treat or prevent COVID-19.